Data coverage, completeness and provenance for ENTROPY NEURODYNAMICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0310 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0300 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0300 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0300 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0290 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ENP/prices · Price parameters and adjustment semantics
Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States. The company's lead program candidate is TRP-8803, a formulation of IV-infused psilocin that completed Phase 2 clinical trial for the treatment of binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. It is also involved in the development of TRP-8802, a synthetic and oral psilocybin currently under phase 2a clinical trial for the treatment of binge eating, as well as under phase 2 clinical stage for the treatment of fibromyalgia and irritable bowel syndrome. The company was formerly known as Tryptamine Therapeutics Limited and changed its name to Entropy Neurodynamics Limited in November 2025. Entropy Neurodynamics Limited was founded in 2019 and is based in Camberwell, Australia.
Website: https://entropyneurodynamics.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ENP/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 25 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 25 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 29 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 30 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ENP
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ENP/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ENP/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ENP/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ENP/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ENP
Free tier — instant API key. Built for AI agents.